This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Lupin, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Vaibhav Dyaneshwar Deokar: Innovator in Pharmaceutical Composition
Introduction
Vaibhav Dyaneshwar Deokar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for therapeutic proteins.
Latest Patents
His most recent patent is titled "Stable pharmaceutical composition of Etanercept in a phosphate citrate buffer with glycine as an anti-aggregating agent." This invention relates to stable pharmaceutical compositions comprising tumor necrosis factor receptor Fc fusion protein (TNFR:Fc). It details methods of manufacturing the composition, administration techniques, and kits containing the formulation. Vaibhav holds 1 patent in this area.
Career Highlights
Throughout his career, Vaibhav has worked with prominent companies such as Lupin, Inc. and Lupin Atlantis Holdings SA. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Anjali Deepak Apte-Deshpande and Rustom Sorab Mody. Their collaboration has likely fostered a productive environment for innovation and development.
Conclusion
Vaibhav Dyaneshwar Deokar's work in pharmaceutical compositions exemplifies the impact of innovation in healthcare. His contributions continue to advance the field and improve therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile